Russell Kevin Klass bought $20k of ZOMDF
Sr Vice President of Sales at Zomedica Corp.. 500,000 shares at an average of $0.04, traded Aug 11, 2025, filed Aug 12, 2025.
Score components
- +15RoleOfficer
- 0Trade size$20k at market
- +3Relative to holdingsHoldings up 14%
- +8Price context74% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +180.5%, 3m +129.3%, 6m +217.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001654954-25-009402, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 11, 2025 | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $9,500 | 3,950,030 | Aug 12, 2025 |
| Aug 11, 2025 | POpen-market purchase Common Stock, without par value | +250,000 | $0.04 | $10k | 4,200,030 | Aug 12, 2025 |
Related signals
Other insiders at Zomedica Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 56Moderate | Zomedica Corp. | Russell Kevin Klass Sr. Vice President, Sales | $11k 104,000 shares | - | |
| 36Weak | Zomedica Corp. | Russell Kevin Klass Vice President of Sales | $23k 216,899 shares | +4% | |
| 43Moderate | Zomedica Corp. | Johnny D Powers director | $21k 200,000 shares | +5% | |
| 51Moderate | Zomedica Corp. | Johnny D Powers director | $32k 300,000 shares | +8% | |
| 44Moderate | Zomedica Corp. | Johnny D Powers director | $56k 500,000 shares | +15% | |
| 55Moderate | Zomedica Corp. | Larry C Heaton II CEO | $28k 250,000 shares | +25% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $15k 150,000 shares | +3% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $12k 120,000 shares | +2% | |
| 23Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $475 5,000 shares | +0% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $20k 253,007 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.